Scinai Immunotherapeutics Ltd. Annual Operating Income (Loss) in USD from 2021 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Scinai Immunotherapeutics Ltd. annual/quarterly Operating Income (Loss) history and growth rate from 2021 to 2023.
  • Scinai Immunotherapeutics Ltd. Operating Income (Loss) for the quarter ending June 30, 2023 was -$2.6M, a 20.5% increase year-over-year.
  • Scinai Immunotherapeutics Ltd. annual Operating Income (Loss) for 2023 was $9.71M.
  • Scinai Immunotherapeutics Ltd. annual Operating Income (Loss) for 2022 was -$11.1M, a 1.83% decline from 2021.
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $9.71M +$20.8M Jan 1, 2023 Dec 31, 2023 20-F 2024-05-15
2022 -$11.1M -$199K -1.83% Jan 1, 2022 Dec 31, 2022 10-K 2023-04-17
2021 -$10.9M Jan 1, 2021 Dec 31, 2021 10-K 2023-04-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.